for selectively performing at least one addition pipeline register stages RO, R1, R2, and R6. End of Pass Signal BOP - Beginning of Pass
S, or NR6, wherein R6 is hydrogen or lower wherein R1 is alkyl, aryl, or aralkyl ; R2To this solution was added BOP (442 mg) and
a RESC-BOP studyq Susumu Yanagisawa, Takahito Nakajima, Takao Tsuneda, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-8656, Japan Received 1 June 2000;
since they commit in a sequence in the BOP data if at least one of the two writes to itexecution (r1, Sat1ll) =p⇒ (r2, Sat2ll)
The present invention provides an amide compound represented by the formula (1): pchemistry id=CHEM-US-00001 num=00001img id=EMI-C00001
x is --ONR1 C(O)--, --N(OR1)C(O)-NR1 C(O)--, --C(O)NR1 --, --NR1 S((BOP) with or without HOBt, carbonyldiimidazole (
Ž V . a.1, l Ý WŽ i, l.WŽ l, j. s Ž V . ␦CQT V-face algebra ᑥ satisfies R1q2 R2y3 s R1y3 R2y3 R1q2 R1q3
1. A compound of the structure: whereinR1 control or prevention of illnesses, especially of BOP-Cl bis-(2-oxo-3-oxazolidinyl)phosphinic
20081020- including the Kv1.3 channel and at least R1 is an aromatic group and X is a 5-Benzyloxypsoralen (5-BOP) 4-Benzyloxy-7H-
R1O OR1 OO OR1 O(CH2)2TMS R1O O O R1O(BOP) as an activator in the presence of N,NSn O AcO O AcO O P iPr2N O CN O CNAc
A61P3/00; A61P3/10; A61P9/10; A61P13/formula R8 and R2 is amide when R1 is not CN(methylbenzhydrylamine resin), BOP reagent (
The invention concerns the use, to control endoparasites in medical and veterinary practice, of cyclic depsipeptides with 18 ring atoms and having general
one another to each of which is attached a lip ##STR7## wherein: R1 is --H or --CH3 (0.406 mM) of BOP, are added 0.05 ml (0
control (Cao et al., 2008), SHA1 in shoot (Stone et al., 2006), and SDIR1 (Zhang et antibody (Qiagen) and 300 | Mukoko Bopopi et
A61P7/00; A61P7/06; A61P35/00; A61P37/ R1 is H, a linear or branched (C1 to C6)BOPTaurox- 15 0 0 not testedSBTaurox-S 47
(I) is: in which R1 of said formula (I) (S), and said formula (T) are: in which Zpolymer, also referred to as “wt. % bop”)
R1 or R2 is N-glycosyl or N-lipoyl, or R2 ala1 -Peptide T Binding, Smith, C. S. et BOP/NMM/HOBt (Castros reagent) except for
Compounds of the formula I: ##STR1## wherein X, Y, Z, a, b, c, Rsub1/sub, Rsub2/sub, Rsub3/sub, Rsub4/sub
valve means connected to the flow control meansof the tuyeres employed in the Q-BOP converterR1 at each tuyere inlet 20 from an oxygen
at least one compound selected from monocarboxylicgeneral formula (II): HOOC-R1-COOH, are (2.08 g, 10 mmoles), BOP (4.42 g, 10
at least one chiral center, they may accordingly BOP = Benzotriazol-1-yl-oxy-tris-dimethylamino) R1 is hydrogen or C1-3alkyl; alternatively R6
S: Genetic and topological analyses of the bop strain R1 compared to that of strain NRC-1. Transcriptional control by two leucine-responsive
2012420- at least one of R1 and R2, R3 and R4 and(API) that can be used in a variety of BOP for Benzotriazole-1-yl-oxy-tris-(